Finance

Mga Listahan
EW:NYSE
Edwards Lifesciences Corp
$85.27
-1.31%
(-1.13) 1D
Okt 13, 4:00:05 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa EW...
Buksan
$86.55
Mataas
$86.77
Mababa
$85.08
Mkt. cap
49.15B
Avg. na dami
3.50M
Dami
1.66M
P/E ratio
49.33
Mataas nang 52-wk
$96.29
Mababa nang 52-wk
$72.40
EPS
$1.73
Beta
0.87
Mga natitirang share
576.40M
Bilang ng mga empleyado
16K
Buksan
$86.55
Mataas
$86.77
Mababa
$85.08
Mkt. cap
49.15B
Avg. na dami
3.50M
Dami
1.66M
P/E ratio
49.33
Mataas nang 52-wk
$96.29
Mababa nang 52-wk
$72.40
EPS
$1.73
Beta
0.87
Mga natitirang share
576.40M
Bilang ng mga empleyado
16K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Tungkol sa Edwards Lifesciences Corp
CEO-
Mga Empleyado16K
Itinatag1958
HeadquartersIrvine, California, Estados Unidos
Sektor-
Mga rating ng analyst
Batay sa 17 (na) analyst na nagbigay ng mga rating ng stock sa EW sa nakalipas na 3 buwan
Strong buy
Pagbili
14
Pag-hold
3
Pagbebenta
0
12 buwang forecas
Batay sa 17 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa EW sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $85.27
$110.00 (+29.00%)
Average
$104.07 (+22.05%)
Pinakamababa
$85.00 (-0.32%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Marie Thibault
BTIG
Buy
Reiterated
$110.00
+29%
10/09/2026
Patrick Wood
UBS
Buy
Maintained
$110.00
+29%
10/07/2026
Christopher Pasquale
Barclays
Buy
Initiated
$110.00
+29%
10/07/2026
Matt Miksic
Barclays
Buy
Maintained
$110.00
+29%
10/07/2026
Tycho Peterson
Jefferies
Buy
Initiated
$110.00
+29%
10/07/2026
Joanne Wuensch
Citi
Buy
Maintained
$110.00
+29%
10/05/2026
Kendall Au
RBC Capital
Buy
Maintained
$110.00
+29%
10/01/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
$101.00
+18.4%
09/28/2026
Adam Maeder
Piper Sandler
Buy
Maintained
$101.00
+18.4%
09/21/2026
Matthew Taylor
Jefferies
Buy
Maintained
$105.00
+23.1%
09/11/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/10/2026
William Plovanic
Canaccord Genuity
Hold
Maintained
$85.00
-0.3%
08/03/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
$105.00
+23.1%
07/28/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$110.00
+29%
07/24/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
07/24/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$95.00
+11.4%
07/24/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
$110.00
+29%
07/23/2026
Travis Steed
Bank of America Securities
Buy
Maintained
$100.00
+17.3%
07/21/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$104.00
+22%
07/23/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$105.00
+23.1%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$100.00
+17.3%
07/06/2026
David Roman
Goldman Sachs
Buy
Maintained
$98.00
+14.9%
06/15/2026
Krish Sankar
TD Cowen
Buy
Reiterated
$104.00
+22%
06/02/2026
David Toung
Argus Research
Buy
Maintained
-
-
05/21/2026
David Rescott
Robert W. Baird
Hold
Maintained
$87.00
+2%
04/24/2026
Michael Polark
Wolfe Research
Buy
Upgraded
$92.00
+7.9%
04/01/2026
Danielle Antalffy
UBS
Hold
Maintained
$90.00
+5.5%
02/12/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
$100.00
+17.3%
02/11/2026
Huling ulat
Hul 23, 2026
Fiscal period
Q2 2026
$0.78 / $0.74
+5.11%lumampas
Kita / Pagtataya (USD)
1.74B / 1.70B
+2.44%lumampas
Earnings call para sa Fiscal Q2 2026
Hinihintay ang earnings call
Sa isang sulyap
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
1.55B
1.57B
1.65B
1.74B
Gastusin sa mga naibentang produkto
345.20M
343.00M
362.60M
392.40M
Halaga ng kita
345.20M
343.00M
362.60M
392.40M
Mga gastos sa pananaliksik at pag-develop
280.70M
267.70M
263.30M
278.90M
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
514.60M
601.20M
522.20M
561.20M
Gastos sa pagpapatakbo
782.80M
854.60M
771.30M
829.10M
Kabuuang gastos sa pagpapatakbo
1.13B
1.20B
1.13B
1.22B
Kita sa pagpapatakbo
425.10M
372.00M
514.70M
519.50M
Iba pang hindi kita sa pagpapatakbo
1.10M
2.30M
69.90M
-25.00M
EBT na may mga hindi karaniwang item
348.40M
90.40M
459.00M
519.80M
EBT na hindi kasama ang mga hindi karaniwang item
444.50M
464.00M
603.60M
511.10M
Gastos sa buwis sa kita
56.10M
26.20M
78.30M
278.40M
Epektibong rate ng buwis
16.10%
28.98%
17.06%
53.56%
Iba pang gastos sa pagpapatakbo
-12.50M
-14.30M
-14.20M
-11.00M
Net na kita
291.10M
91.20M
380.70M
241.90M
Margin ng kabuuang kita
18.74%
5.81%
23.09%
13.89%
Kita bawat share
0.67
0.58
0.78
0.78
Kita sa interes at investment
16.70M
114.20M
17.40M
15.00M
Gastos sa interes
-
-20.40M
-
-
Mga net na gastos sa interes
16.70M
93.80M
17.40M
15.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
464.30M
414.70M
555.60M
562.20M
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-33.90M
-
-
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google